![](/img/cover-not-exists.png)
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II
Goldstein, Ellie J C, Citron, Diane M, Gerding, Dale N, Wilcox, Mark H, Gabryelski, Lori, Pedley, Alison, Zeng, Zhen, Dorr, Mary BethJournal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciz1151
Date:
December, 2019
File:
PDF, 147 KB
2019